|
JRC Publications Repository >
Browsing by Author MORGENSTERN Alfred
Showing results 5 to 24 of 97
| Publication Year | Title | Author(s), Editor(s), Other Contributor(s) | Publication Type | | 2011 | An Alpha-Particle Emiting Radiopeptide (213 Bi-DOTA-PESIN) for Therapy of Prostate Cancer | WILD D.; FRISCHKNECHT M.; ZHANG H.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; BOISCLAIR J.; PROVENCHER-BOLLIGER A.; REUBI Jean-Claude; MAECKE H. R. | Articles in Journals |
| 2013 | Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenation | WULBRAND Christian; SEIDL C.; GAERTNER F. C.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.; SENEKOWITSCH-SCHMIDTKE R. | Articles in Journals |
| 2010 | [An(H2O)9](CF3SO3)3 (An=U-Cm, Cf): Exploring Their Stability, Structural Chemistry, and Magnetic Behavior by Experiment and Theory | APOSTOLIDIS Christos; SCHIMMELPFENNIG Bernd; MAGNANI Nicola; LINDQVIST-REIS Patric; WALTER Olaf; SYKORA Richard; MORGENSTERN Alfred; COLINEAU Eric; CACIUFFO Roberto; KLENZE R., et al | Articles in Journals |
| 2009 | Analysis of DNA double-strand breaks in gastric cancer cells after treatment with 213Bi-immunoconjugates | SEIDL C.; FRANK Annette; PFOST B.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SENEKOWITSCH-SCHMIDTKE Reingard | Contributions to Conferences |
| 2011 | Analysis of Patient Survival in a Phase 1 Trial of Systemic Targeted Alpha Therapy for Metastatic Melanoma | ALLEN B. J.; SINGLA A; RAJA C.; RIZVI S.; GRAHAM P.; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; MORGENSTERN Alfred | Articles in Journals |
| 2006 | Antibody-guided Alpha Radiation Effectively Damages Fungal Biofilms | MARTINEZ L.r.; BRYAN R.a.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; CASADEVALL A.; DADACHOVA E. | Articles in Journals |
| 2012 | Bismuth-213 and Actinium-225 – Generator Performance and Evolving Therapeutic Applications of Two Generator-Derived Alpha-Emitting Radioisotopes | MORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos | Articles in Journals |
| 2008 | Bismuth-213 Radioimmunotherapy with C595 Anti¿MUC1 Monoclonal Antibody in an Ovarian Cancer Ascites Model | SONG E.; QU C. F.; RIZVI S.; RAJA C.; BERETOV J.; MORGENSTERN Alfred; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; PERKINS A. D. | Articles in Journals |
| 2007 | Breaking Chemo- and Radioresistance with [Bi-213]anti-CD45 Antibodies in Leukemia Cells | FRIESEN C.; GLATTING G.; KOOP B.; SCHWARZ K.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; DEBATIN K.m.; RESKE S.n. | Articles in Journals |
| 2012 | Clinical aspects and future advances of targeted alpha therapy in oncology | KRATOCHWIL Clemens; GIESEL Frederik; MORGENSTERN Alfred | Contributions to Conferences |
| 2012 | Combined 213Bi-DTPA- F3 and paclitaxel treatment of peritoneal spread of human ovarian carcinoma in a mouse model enhances therapeutic efficacy due to enhanced induction of apoptosis and G2/M phase cell-cycle arrest | SEIDL C.; VALLON M.; BLECHERT B.; GILBERTZ K.-P.; AICHLER M; FEUCHTINGER A; GÄRTNER Florian; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M. | Contributions to Conferences |
| 2012 | Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model | GUSTAFSSON Anna; BAECK Tom; ELGQVIST Joergen; JACOBSSON Lars; HULTBORN Ragnar; ALBERTSSON Per; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; JENSEN Holger; LINDEGREN Sture | Articles in Journals |
| 2006 | Control of Prostate Cancer Spheroid Growth Using (213)Bi-labeled Multiple Targeted Alpha Radioimmunoconjugates | WANG J.; RIZVI S.m.a.; MADIGAN C.; COZZI P.j.; POWER C.a.; QU C.f.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; RUSSEL P.j.; ALLEN B.j., et al | Articles in Journals |
| 2009 | Cross Sections of the Reaction 231Pa(d,3n)230U for Production of 230U/226Th for Targeted Alpha Therapy | MORGENSTERN Alfred; LEBEDA O.; STURSA J.; CAPOTE R.; SIN M.; BRUCHERTSEIFER Frank; ZIELINSKA Barbara; APOSTOLIDIS Christos | Articles in Journals |
| 2008 | Cross-sections of the Reaction 232Th(p,3n)230Pa for Production of 230U for Targeted Alpha Therapy | MORGENSTERN Alfred; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; CAPOTE R.; GOUDER Thomas; SIMONELLI Federica; SIN M.; ABBAS Kamel | Articles in Journals |
| 2005 | Cyclotron Production of Ac-225 for Targeted Alpha Therapy | APOSTOLIDIS CHRISTOS; MOLINET Roger; MCGINLEY JOHN; ABBAS KAMEL; MOELLENBECK J.; MORGENSTERN ALFRED | Articles in Journals |
| 2005 | Cyclotron Production of Ac-225 for Targeted Alpha Therapy | APOSTOLIDIS CHRISTOS; MOLINET Roger; MCGINLEY JOHN; MOELLENBECK J.; MORGENSTERN ALFRED; ABBAS KAMEL | Articles in Journals |
| 2008 | The Cytokinesis-Block Micronucleus Assay as a Biological Dosimeter for Targeted Alpha Therapy | SONG E.; RIZVI S.; QU C. F.; RAJA C.; YUEN J.; LI Y.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; ALLEN B. J. | Articles in Journals |
| 2006 | Cytotoxicity of PAI2, C595 and Herceptin Vectors Labeled with the Alpha-Emitting Radioisotope Bismuth-213 for Ovarian Cancer Cell Monolayers and Clusters | SONG Y.j.; QU C.f.; RIZVI S.m.a.; LI Y.; ROBERTSON G.; RAJA C.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; PERKINS A.c.; ALLEN Barry J. | Articles in Journals |
| 2013 | Decay data measurements on 213Bi using recoil atoms | MAROULI MARIA; SULIMAN GABRIEL; POMME Stefaan; VAN AMMEL Raf; JOBBAGY VIKTOR; STROH HEIKO; DIKMEN H.; PAEPEN Jan; DIRICAN A.; BRUCHERTSEIFER Frank, et al | Articles in Journals |
Showing results 5 to 24 of 97
|
